Cas:1249526-67-7 2-Amino-4-fluorobenzimidazole manufacturer & supplier

Chemical Name:2-Amino-4-fluorobenzimidazole

CAS.NO:1249526-67-7

Synonyms:4-Fluoro-1H-benzo[d]imidazol-2-amine;2-Amino-4-fluorobenzimidazole

Molecular Formula:C₇H₆FN₃

Molecular Weight:151.14100

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:N/A

Density:1.487±0.06 g/cm3

Index of Refraction:

PSA:55.43000

Exact Mass:151.05500

LogP:1.21430

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 4-Fluoro-1H-benzo[d]imidazol-2-amine chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-Amino-4-fluorobenzimidazole physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,4-Fluoro-1H-benzo[d]imidazol-2-amine Use and application,2-Amino-4-fluorobenzimidazole technical grade,usp/ep/jp grade.

Related News: ��We believe the iLet Bionics Pancreas System represents a true breakthrough therapy for the management of glycemia, particularly in type 1 diabetes,�� said Ed Damiano, President and CEO of Beta Bionics. ��We are partuclarly excited by the possibility that the iLet may be able to provide safer and more effective therapy in far more people than current therapies due to its simplicity of use.�� 2-Amino-4-fluorobenzimidazole manufacturer FT819 is derived from a clonal master engineered induced pluripotent stem cell (iPSC) line with complete elimination of T-cell receptor (TCR) expression and a novel 1XX CAR targeting CD19 inserted into the T-cell receptor alpha constant (TRAC) locus. 2-Amino-4-fluorobenzimidazole supplier ��We believe the iLet Bionics Pancreas System represents a true breakthrough therapy for the management of glycemia, particularly in type 1 diabetes,�� said Ed Damiano, President and CEO of Beta Bionics. ��We are partuclarly excited by the possibility that the iLet may be able to provide safer and more effective therapy in far more people than current therapies due to its simplicity of use.�� 2-Amino-4-fluorobenzimidazole vendor FT819 is derived from a clonal master engineered induced pluripotent stem cell (iPSC) line with complete elimination of T-cell receptor (TCR) expression and a novel 1XX CAR targeting CD19 inserted into the T-cell receptor alpha constant (TRAC) locus. 2-Amino-4-fluorobenzimidazole factory The company-backed investigation was based on interviews with more than 100 people, the May 20 memo to Lilly employees said. However, the memo did not respond to all concerns employees raised in their April complaint, which Reuters reviewed.